TuCann Medical offers an innovative peripheral intravenous catheter (PIVC) designed to reduce the risk of cannula-associated bloodstream infections (CABSIs). The PIVC streamlines insertion procedures and lessens reliance on a strictly sterile field, improving patient safety and hospital efficiency.
Funding
Funding not disclosed
Founders
Product
Problem
Peripheral intravenous catheters (PIVCs), essential for administering treatments to a significant portion of hospitalized patients, are associated with a substantial risk of bloodstream infections. These cannula-associated bloodstream infections (CABSIs) can lead to severe patient outcomes and impose considerable financial burdens on healthcare systems.
Solution
TuCann Medical has developed an innovative PIVC designed to mitigate the risk of CABSIs. The device streamlines the insertion procedure, reducing the number of steps required by healthcare professionals and lessening the dependency on maintaining a fully sterile field. This enhanced safety profile not only protects patients from dangerous bacterial contamination but also contributes to improved hospital operational efficiency by reducing procedure time and preventing costly infection-related complications. Furthermore, the design aims to minimize packaging waste, aligning with sustainability objectives.
Target Audience
The primary customers are hospitals, healthcare networks, and clinicians seeking to reduce the incidence of PIVC-associated bloodstream infections and improve procedural efficiency.
Features
- Cannula design engineered to reduce procedural steps for insertion.
- Integrated features that decrease reliance on a strictly sterile field during placement.
- Focus on aseptic technique to minimize contamination pathways.
- Reduced packaging volume for improved environmental sustainability.
- Intended to decrease the incidence of cannula-associated bloodstream infections (CABSIs).